In cases of failed convergence with log-binomial regression (for total AE and other AE), a modified Poisson regression was used to calculate RRs with 95% CIs from robust standard errors estimated using the sandwich estimator 41
Second, dual receptor activation changes how the body processes the medication, affecting how long side effects last during dose escalation
For example, if you paused at week 4 with 8 units per week, and are ready to resume at week 6, move up to 12 units per week when you return
Tirzepatide and semaglutide, in rare cases, may cause serious side effects, which include: Pancreatitis (inflammation of the pancreas) Vision problems Kidney problems, including kidney failure Gallbladder problems Pulmonary aspiration during sedation or procedures (tell your healthcare provider you use tirzepatide or semaglutide if you are planning any medical procedures) Before using tirzepatide or semaglutide, tell your healthcare provider about all of your medical conditions, medical history, and family history
Stay at current dose if: GI symptoms are still present but manageable
It behaved like GLP-1, but lasted much longer
